Embecta (EMBC) FCF Margin (2020 - 2026)

Embecta (EMBC) posted FCF Margin of 13.8% for Q1 2026, up 117.08% sequentially from 6.36% in Q4 2025, and up 156.0% YoY from 5.39% in Q1 2025.

Embecta (EMBC) FCF Margin (2020 - 2026) Analysis & Trends

Embecta has reported FCF Margin for 7 years, with the latest figure at 13.8% in Q1 2026.

Quarterly FCF Margin rose 156.0% year-over-year to 13.8% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 19.64% (up 1596.0% YoY) and the FY2025 annual result came in at 16.88%, up 1511.0% from the prior year.
FCF Margin rose to 13.8% in Q1 2026 per EMBC's latest filing, from 6.36% in the prior quarter.
Over five years, FCF Margin peaked at 64.55% in Q1 2022 and troughed at 6.78% in Q1 2023.
A 5-year average of 11.75% and a median of 9.3% in 2024 frame the typical range for FCF Margin.
The sharpest annual moves came in 2023 and 2025: FCF Margin slumped 7134 bps in 2023, then soared 3167 bps in 2025.
Over 5 years, FCF Margin stood at 20.2% in 2022, then plunged by 128 bps to 5.7% in 2023, then surged by 54 bps to 2.6% in 2024, then soared by 345 bps to 6.36% in 2025, then surged by 117 bps to 13.8% in 2026.
According to Business Quant data, FCF Margin over the past three periods registered 13.8%, 6.36%, and 29.05% for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Margin (Qtr)
1	Intuitive Surgical	132.71 Bn	127.50 Bn	1.96 Bn	32.79%
2	Becton Dickinson	51.57 Bn	50.71 Bn	2.32 Bn	12.70%
3	Alcon	35.52 Bn	34.17 Bn	1.68 Bn	4.82%
4	Resmed	33.28 Bn	31.81 Bn	861.22 Mn	27.57%
5	Medline	27.86 Bn	25.18 Bn	2.22 Bn	7.86%
6	West Pharmaceutical Services	25.15 Bn	24.71 Bn	329.20 Mn	9.26%
7	Solventum	15.31 Bn	14.91 Bn	1.29 Bn	6.52%
8	Cooper Companies	14.86 Bn	14.72 Bn	735.40 Mn	8.91%
9	Baxter International	13.63 Bn	11.48 Bn	1.03 Bn	6.11%
10	Embecta	319.59 Mn	101.39 Mn	153.30 Mn	14.98%

Download Data